Tue, Jul
58 New Articles

CMS Advises Alpla on Joint Venture with Inden Pharma

CMS Advises Alpla on Joint Venture with Inden Pharma

Deals and Cases
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

CMS has advised the Alpla Group on establishing a pharmaceutical packaging market joint venture with Spain's Inden Pharma.

"The Alpla Group and Inden Pharma have strengthened their presence in the pharmaceutical market by founding a joint venture," CMS informed. "Alpla Pharma is contributing production sites in Greece and Poland to the cooperation and Inden Pharma two plants in Spain. Together they plan to set up a site in Germany and triple their production over the next five years."

The Alpla Group is an Austrian plastics manufacturer and plastics recycler, specializing in blow-molded bottles and caps, injection-molded parts, preforms, and tubes.

The CMS team was led by Austria-based Partner Alexander Rakosi and included Partners Hans Lederer and Dieter Zandler, Lawyers Florian Mayer and Vanessa Horaceck, Associates Anna Hiegelsperger, Livia Landskron, and Ramona Mujanovic, Legal Assistants Rupert Riedl and Hannah Gierlinger, Legal Trainee Rebecca Herlitz, as well as Poland-based Partner Blazej Zagorski, Senior Associate Joanna Bialoskorska, Lawyer Aleksandra Dalecka, and teams from the firm’s Spanish and German offices.

Editor's Note: After this article was published, CEE Legal Matters learned that Herbert Smith Freehills Spain reportedly advised Inden Pharma.

Our Latest Issue